drugset / Trial / NCT04942522

Application of Probiotic PS128 in Children With ASD

NCT04942522 ↗

Phase 1 Unknown 80 enrolled Yan Hao
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to explore the role of probiotics PS128 in improving gastrointestinal dysfunction and core behavioral symptoms in children with ASD, and investigate the underlying etiological mechanisms of ASD.

Timeline

Start
2021-06-06
Primary completion
2023-06-06
Completion
2023-10-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject PS128 Unknown 6e+10 unknown Oral